These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 8627020

  • 1. Differences in the incidence of hepatitis B and human immunodeficiency virus infections among injecting drug users.
    Levine OS, Vlahov D, Brookmeyer R, Cohn S, Nelson KE.
    J Infect Dis; 1996 Mar; 173(3):579-83. PubMed ID: 8627020
    [Abstract] [Full Text] [Related]

  • 2. Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study.
    Ruan Y, Qin G, Yin L, Chen K, Qian HZ, Hao C, Liang S, Zhu J, Xing H, Hong K, Shao Y.
    AIDS; 2007 Dec; 21 Suppl 8():S39-46. PubMed ID: 18172390
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis D virus infections among injecting drug users with and without human immunodeficiency virus infection in Taiwan.
    Hsieh MH, Wang SC, Hsieh MY, Huang CF, Yeh ML, Yang JF, Chang K, Lin WR, Lin CY, Chen TC, Huang JF, Dai CY, Tsai JJ, Chuang WL, Yu ML.
    Kaohsiung J Med Sci; 2016 Oct; 32(10):526-530. PubMed ID: 27742037
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS, Brajachand N, Singh HL, Singh YM.
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective.
    Strathdee SA, Galai N, Safaiean M, Celentano DD, Vlahov D, Johnson L, Nelson KE.
    Arch Intern Med; 2001 May 28; 161(10):1281-8. PubMed ID: 11371255
    [Abstract] [Full Text] [Related]

  • 8. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study.
    van Beek I, Dwyer R, Dore GJ, Luo K, Kaldor JM.
    BMJ; 1998 Aug 15; 317(7156):433-7. PubMed ID: 9703523
    [Abstract] [Full Text] [Related]

  • 9. Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md.
    Nelson KE, Vlahov D, Solomon L, Cohn S, Muñoz A.
    Arch Intern Med; 1995 Jun 26; 155(12):1305-11. PubMed ID: 7778962
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program.
    Månsson AS, Moestrup T, Nordenfelt E, Widell A.
    Scand J Infect Dis; 2000 Jun 26; 32(3):253-8. PubMed ID: 10879594
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hepatitis B virus sero-profiles and genotypes in HIV-1 infected and uninfected injection and Non-injection drug users from coastal Kenya.
    Webale MK, Budambula V, Lihana R, Musumba FO, Nyamache AK, Budambula NL, Ahmed AA, Ouma C, Were T.
    BMC Infect Dis; 2015 Jul 30; 15():299. PubMed ID: 26223795
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of hepatitis B, tetanus, hepatitis A, human immunodeficiency virus and feasibility of vaccine delivery among injecting drug users in Bangkok, Thailand, 2003-2005.
    Sunthornchart S, Linkins RW, Natephisarnwanish V, Levine WC, Maneesinthu K, Lolekha R, Tappero JW, Trirat N, Muktier S, Chancharastong P, Fox K, Donchalermpak S, Vitek C, Supawitkul S.
    Addiction; 2008 Oct 30; 103(10):1687-95. PubMed ID: 18705685
    [Abstract] [Full Text] [Related]

  • 17. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD, Hagan H, Garfein RS, Sabin K, Weinbaum C, Thiede H.
    J Urban Health; 2007 May 30; 84(3):436-54. PubMed ID: 17356901
    [Abstract] [Full Text] [Related]

  • 18. Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users.
    Li JR, Gong RY, Tian KL, Wang J, Wang YX, Huang HJ.
    World J Gastroenterol; 2007 Apr 28; 13(16):2357-62. PubMed ID: 17511038
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus in three groups of populations at high risk of HIV infection in Amritsar (Punjab), Northern India.
    Jindal N, Arora U, Singh K.
    Jpn J Infect Dis; 2008 Jan 28; 61(1):79-81. PubMed ID: 18219142
    [Abstract] [Full Text] [Related]

  • 20. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
    Panda S, Chatterjee A, Bhattacharjee S, Ray B, Saha MK, Bhattacharya SK.
    Int J STD AIDS; 1998 Apr 28; 9(4):214-8. PubMed ID: 9598748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.